Symbol="NXTC"
AssetType="Common Stock"
Name="NextCureÂ  Inc"
Description="NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other diseases related to the immune system by restoring normal immune function. The company is headquartered in Beltsville, Maryland."
CIK="1661059"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="42595200"
EBITDA="-69297000"
PERatio="None"
PEGRatio="None"
BookValue="4.972"
DividendPerShare="0"
DividendYield="0"
EPS="-2.31"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.255"
ReturnOnEquityTTM="-0.417"
RevenueTTM="0"
GrossProfitTTM="-54199000"
DilutedEPSTTM="-2.31"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="9.52"
PriceToBookRatio="0.206"
EVToRevenue="1.623"
EVToEBITDA="3.078"
Beta="0.0767"
num_52WeekHigh="4.56"
num_52WeekLow="1.16"
num_50DayMovingAverage="1.708"
num_200DayMovingAverage="1.611"
SharesOutstanding="27840000"
DividendDate="None"
ExDividendDate="None"
symbol="NXTC"
open="1.52"
high="1.59"
low="1.50"
price="1.53"
volume="69364.00"
latest_trading_day="2023-08-22"
previous_close="1.57"
change="-0.04"
change_percent="-2.5478%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="49063"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="1143"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_negative_thumbnail_id_2="1121"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0154.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="607"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_positive_thumbnail_id_2="612"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0096.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
